EPISODE · Jul 26, 2017 · 8 MIN
Indel derived tumour-specific neoantigens: The Lancet Oncology: Aug 2017
from Listen to The Lancet Oncology · host The Lancet
Samra Turajlic discusses the contribution of small insertions and deletions to tumour-specific antigen analyses.
Embed this episode
NOW PLAYING
Indel derived tumour-specific neoantigens: The Lancet Oncology: Aug 2017
0:00
8:01
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Listen to The Lancet Oncology?
This episode is 8 minutes long.
When was this Listen to The Lancet Oncology episode published?
This episode was published on July 26, 2017.
Can I download this Listen to The Lancet Oncology episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!